A multi-index detection kit for assessing the effects of perifosine-mediated cellular oxidative stress toxicity and its application.
By integrating the detection of cell proliferation, apoptosis, and oxidative stress indicators through a multi-index detection kit, the problem of inconsistent assessment of the toxicity effect of perifoxin in existing technologies has been solved, achieving standardization and traceability of drug safety evaluation results, and is applicable to the toxicity evaluation of various cell lines.
Patent Information
- Application Number
- CN202610080476.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2026-01-21
- Publication Date
- 2026-11-10
- Estimated Expiration
- 2046-01-21
AI Technical Summary
The lack of standardized, multi-indicator comprehensive judgment process in existing technologies leads to inconsistent and low reproducibility in the assessment of the toxic effects of perifoxin on normal cells or non-target cells, which limits its application in drug safety evaluation and preclinical screening.
This invention provides a multi-index detection kit that integrates the detection of indicators such as cell proliferation, apoptosis, reactive oxygen species, lipid peroxidation, and glutathione. By optimizing reagent combinations and standardizing operating procedures, a reproducible and comparable toxicity assessment system is constructed, and a comprehensive evaluation is conducted using Student's t-test and two-way ANOVA.
It enables an objective, comprehensive, and traceable evaluation of perifosine-mediated cellular oxidative stress toxicity, improves the reproducibility and comparability of test results, and has good versatility and scalability, making it suitable for drug toxicity evaluation of various in vitro cell lines.
Smart Images

Figure CN122189143B_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of biomedical technology, and in particular to a multi-index detection kit for evaluating the effects of perifosine-mediated cellular oxidative stress toxicity and its application. Background Technology
[0002] Perifosine, an oral alkyl phospholipid antitumor drug, exerts its antitumor effect by inhibiting the Akt signaling pathway. Although it has shown promising antitumor potential in preclinical studies, a unified and reproducible evaluation standard for its toxic effects on normal cells or non-target cells has not yet been established. Currently, related studies rely heavily on decentralized and non-standardized detection methods. For example, indicators such as cell proliferation, apoptosis, reactive oxygen species (ROS), lipid peroxidation (LPO), and glutathione (GSH) are usually measured separately, lacking an integrated detection system and a unified interpretation process. This decentralized detection leads to poor data comparability and low reproducibility, severely limiting the application of perifosine in drug safety evaluation and preclinical screening. Summary of the Invention
[0003] Technical Problem Solved: Addressing the lack of standardized, multi-indicator comprehensive assessment procedures in existing technologies, this invention provides a multi-indicator detection kit and its application for evaluating the cytotoxic effects of perifosine-mediated cellular oxidative stress. This multi-indicator kit integrates relative quantitative detection of oxidative and antioxidant indicators such as cell proliferation, apoptosis, reactive oxygen species (ROS), lipid peroxidation (LPO), and glutathione (GSH), as well as related gene expression (such as Nox, Duox, SOD1, and Gclc), through optimized reagent combinations, standardized operating procedures, and quantitative analysis processes. It constructs a reproducible and comparable multi-indicator toxicity assessment system and judgment rules, thereby enabling objective, comprehensive, and traceable evaluation of perifosine-mediated cytotoxic effects.
[0004] Technical Solution: The present invention provides a multi-index detection kit for evaluating the oxidative stress toxicity effect of perifosine in cells. The multi-index kit includes a cell proliferation detection reagent, a cell apoptosis detection reagent, a fluorescent probe for reactive oxygen species detection and corresponding buffer, a lipid peroxide quantitative detection reagent, a glutathione quantitative detection reagent, a qRT-PCR reagent for detecting the expression level of oxidation-antioxidant related genes, and a detection procedure that includes the order of use of the above reagents.
[0005] Preferably, the cell proliferation detection reagent is CCK-8.
[0006] Preferably, the apoptosis detection reagent is a TUNEL staining reagent.
[0007] Preferably, the fluorescent probe for detecting reactive oxygen species is a DCFH-DA fluorescent probe.
[0008] Preferably, the qRT-PCR reagent includes RNA extraction reagent, reverse transcription reagent, dye, and primers for the Nox, Duox, SOD1, Gclc, and Gapdh genes.
[0009] Preferably, the multi-index detection kit is suitable for the S2 cell line.
[0010] Preferably, the kit is used to detect the oxidative stress toxicity of Perifosine-mediated cells, specifically manifested as inhibition of cell proliferation, promotion of apoptosis, increase of intracellular ROS and LPO levels, decrease of intracellular GSH levels, upregulation of pro-oxidative gene expression levels and downregulation of antioxidant gene expression levels.
[0011] Preferably, the pro-oxidation genes are Nox and Duox, and the antioxidant genes are SOD1 and Gclc.
[0012] This invention also discloses an application of the above-mentioned multi-index detection kit, which is used for drug toxicity screening, drug safety evaluation, and assessment of Perifosine-mediated cellular oxidative stress toxicity in cell biology research.
[0013] Preferably, the application includes the following steps: Step 1, Cell Culture and Drug Treatment: The sample cells are cultured under suitable conditions, treated with different concentrations of Perifosine for a specific time, and then the cells are collected. Step 2, Cell proliferation assay: Use the CCK-8 reagent in the kit to detect cell proliferation according to the operating instructions; Step 3, Apoptosis assay: Using the TUNEL staining reagent in the kit, the apoptosis status was identified according to the operating procedure; Step 4, determination of reactive oxygen species (ROS) content: The amount of ROS generated in cells was detected by fluorescence intensity using the DCFH-DA fluorescent probe and corresponding buffer. Step 5, Oxidative stress level determination: The intracellular LPO and GSH levels were measured using quantitative detection reagents for LPO and GSH, respectively. Step 6, gene expression level detection: RNA was extracted using qRT-PCR reagent, and reverse transcription and PCR reactions were performed to detect the expression levels of Nox, Duox, SOD1, Gclc, and Gapdh genes. Step 7, Statistical Analysis of Data: Student's t-test and two-way ANOVA were used to perform statistical analysis on the test data to comprehensively evaluate the oxidative stress toxicity mediated by Perifosine.
[0014] This invention, through multi-angle detection, confirms that perifosine exposure induces cellular oxidative stress homeostasis imbalance and cytotoxicity, specifically by increasing pro-oxidative levels and decreasing antioxidant levels. Compared with existing technologies, this invention has at least the following outstanding advantages: 1. This invention provides a reproducible and quantifiable technical solution for drug toxicity screening, drug safety evaluation, and cell biology research based on a multi-index quantitative detection and unified judgment process for cell proliferation, apoptosis, and oxidative and antioxidant homeostasis. The multi-index detection kit achieves standardization and reproducibility of detection. By providing a complete reagent combination and a unified detection process, it integrates multiple previously scattered detections into a standardized system, effectively reducing the result variation caused by differences in scattered detection operations, making the detection results highly comparable and traceable, and facilitating the comparison of different data and the reproduction of results. 2. This invention establishes a systematic and quantitative judgment process, employing scientific statistical methods such as Student's t-test and two-way ANOVA to integrate multiple biological parameters such as cell proliferation, apoptosis, oxidative stress indicators, and gene expression. This enables a comprehensive, objective, and systematic assessment of cytotoxicity levels, providing a comprehensive and objective basis for drug screening and safety evaluation. 3. This invention has good versatility and scalability. The kit uses S2 cells as a validation model and can be easily extended to a variety of in vitro cell lines. It also has low dependence on drug type and can be quickly promoted and applied to the evaluation of oxidative stress toxicity of other drugs or toxic factors, and has broad application prospects. Attached Figure Description
[0015] Figure 1 This is a schematic diagram of the detection process for Perifosine-mediated cellular oxidative stress toxicity using the multi-index detection kit of the present invention. Figure 2 The perifosine exposure of this invention induces cytotoxicity: Figure 2 (A) is a line graph of S2 cell proliferation measured by CCK-8, including the proliferation curves of the control group, Perifosine (7.5μM) group, Perifosine (15μM) group and Perifosine (30μM) group at 0h, 24h, 48h and 72h. Figure 2 (B) TUNEL staining results of the control group and the Perifosine (30 μM) treatment group in S2 cells, where Hoechst 33342 (blue) stains DNA and TUNEL staining marks apoptotic cells; Figure 2(C) shows the percentage of TUNEL-positive cells (n=9), scale bar: 50μm; Figure 3 Perifosine, as described in this invention, disrupts the oxidative stress homeostasis equilibrium. Figure 3 (A) Comparison of reactive oxygen species (ROS) levels between the control group and the Perifosine (30 μM) treatment group (n=9); Figure 3 (B) Comparison of lipid peroxide (LPO) levels between the control group and the Perifosine (30 μM) treatment group (n=4); Figure 3 (C) Comparison of glutathione (GSH) levels between the control group and the Perifosine (30 μM) treatment group (n=5); Figure 4 The expression levels of intracellular antioxidant genes after Perifosine exposure according to this invention: Figure 4 (A) Relative expression levels of Nox gene mRNA between the control group and the Perifosine (30 μM) treatment group (n=3); Figure 4 (B) Relative expression levels of Duox gene mRNA between the control group and the Perifosine (30 μM) treatment group (n=3); Figure 4 (C) represents the relative expression level of SOD1 gene mRNA between the control group and the Perifosine (30 μM) treatment group (n=3); Figure 4 (D) represents the relative expression level of Gclc gene mRNA between the control group and the Perifosine (30 μM) treatment group (n=3). Detailed Implementation
[0016] To make the objectives, technical solutions, and advantages of the embodiments of the present invention clearer, the following will be described in conjunction with the accompanying drawings. Figures 1-4 The technical solutions of the embodiments of the present invention are clearly and completely described. Obviously, the described embodiments are only a part of the embodiments of the present invention, not all of them. All other embodiments obtained by those skilled in the art based on the described embodiments of the present invention are within the scope of protection of the present invention.
[0017] Example 1: As Figure 1As shown, the present invention provides a multi-index detection kit for evaluating the oxidative stress toxicity effect of perifosine in cells. The multi-index kit includes a cell proliferation detection reagent, a cell apoptosis detection reagent, a fluorescent probe and corresponding buffer for reactive oxygen species detection, a lipid peroxide (LPO) quantitative detection reagent, a glutathione (GSH) quantitative detection reagent, a qRT-PCR reagent for detecting the expression levels of oxidation-antioxidant related genes, and a detection procedure that includes the order of use of the above reagents. The detection procedure of the kit clearly marks the order of each detection step and key operating points, making it easy for users to follow. The cell proliferation assay reagent is CCK-8, used for accurate and rapid detection of cell proliferation; the apoptosis assay reagent is TUNEL staining reagent, used for specific labeling of apoptotic cells; the reactive oxygen species (ROS) assay fluorescent probe is DCFH-DA fluorescent probe, which oxidizes non-fluorescent DCFH to generate fluorescent dichlorofluorescein (DCF), and the ROS content is detected by fluorescence intensity; the LPO quantitative assay reagent is used to determine the accumulation of lipid peroxides in cells; the GSH quantitative assay reagent is used to quantitatively analyze the content of glutathione in cells; the qRT-PCR reagent includes RNA extraction reagent, reverse transcription reagent, dye, and primers for Nox, Duox, SOD1, Gclc, and Gapdh genes, with Gapdh serving as an internal reference gene to correct the expression level of the target gene. This multi-index detection kit is applicable to the S2 cell line. The kit is used to detect the oxidative stress toxicity of cells mediated by perifosine. The toxicity is specifically manifested in inhibiting cell proliferation, promoting cell apoptosis, increasing intracellular ROS and LPO levels, decreasing intracellular GSH levels, and causing upregulation of pro-oxidative gene expression and downregulation of antioxidant gene expression. The pro-oxidative genes are Nox and Duox, and the antioxidant genes are SOD1 and Gclc.
[0018] Example 2: This invention also discloses the application of a multi-index detection kit, which is used for drug toxicity screening, drug safety evaluation, and assessment of perifosine-mediated oxidative stress toxicity in cell biology research. The kit was used to detect perifosine exposure-induced cytotoxicity (using S2 cells as an example). To systematically evaluate the oxidative stress toxicity of perifosine on cells, after adding perifosine to S2 cells, cell proliferation and apoptosis levels were sequentially detected using CCK-8 and TUNEL assays (e.g., perifosine exposure). Figure 2 As shown), the levels of intracellular reactive oxygen species (ROS), lipid peroxides (LPO), and glutathione (GSH) were detected using oxidative stress-related reagents (e.g., as shown). Figure 3 (as shown), and the expression levels of oxidation-antioxidant related genes were detected by qRT-PCR (e.g. Figure 4 (As shown). The specific experimental process of this embodiment is as follows.
[0019] (I) Cell Culture and Drug Treatment: Sample cells were cultured under suitable conditions and treated with different concentrations of Perifosine for specific durations before cell collection. Specifically, S2 cells were maintained at 28°C in Schneider Drosophila medium (#21720024, Gibco), supplemented with 10% heat-inactivated fetal bovine serum (FBS) (#04-001-1ACS, Bioind). S2 cells were passaged every 3-4 days at a 1:3 ratio with the medium. Perifosine (10mM, SC0227, Beyotime) was added to the medium, with final concentrations of 0 μM (control group) and 30 μM (treatment group). After 48 hours of treatment, S2 cells were collected for subsequent assays.
[0020] (II) Cell proliferation assay: Using the CCK-8 reagent (HY-K0301, MCE) in the kit, cell proliferation was detected according to the operating procedure; the specific operating steps are as follows: (1) Transfer each group of treated S2 cells into a 96-well plate, with approximately 5000 cells per well; (2) Add CCK-8 solution to each well so that the CCK-8 solution occupies 10% of the volume of Schneider Drosophila medium in the well; (3) Incubate at 28℃ for 2 hours; (4) The absorbance of each well was measured at 450 nm using a FlexStation®3 molecular instrument after 0 h, 24 h, 48 h and 72 h of treatment, respectively. (5) All experiments were repeated at least three times, and the average value was used for statistical analysis.
[0021] (III) Apoptosis Assay: The TUNEL staining reagent in the kit was used to identify apoptosis according to the procedure. The one-step TdT-mediated dUTP nick end labeling (TUNEL) apoptosis detection kit (#C1090, Beyotime) was used to identify cell death. The specific procedure is as follows: (1) Fix the S2 cell smears in 4% paraformaldehyde (PFA) for 20 min; (2) Wash three times with 0.3% PBS-Triton X-100 (PBST), each wash lasting 5 minutes; (3) In a light-protected environment, mix the fluorescently labeled solution and TdT enzyme at a ratio of 9:1; (4) Expose the cell smears to the above mixture at 28°C in the dark for 1 hour; (5) Wash three times with 0.3% PBST, 5 min each time; (6) Add Hoechst 33342 (1.0 mg / mL, #C0031, Solarbio) to stain S2 cells for 10 min; (7) Observe and count the proportion of TUNEL positive cells under a fluorescence microscope.
[0022] (iv) Determination of reactive oxygen species (ROS) content: The amount of ROS generated in cells was detected by fluorescence intensity using the DCFH-DA fluorescent probe (S0033, Beyotime) and the corresponding buffer solution; the specific operation steps are as follows: (1) Take S2 cells from each group after treatment and incubate them with DCFH-DA fluorescent probe in the dark for 20 min; (2) After removing the DCFH-DA fluorescent probe, wash the cells three times with 1×PBS and then resuspend the cells. (3) Use an ELISA reader to measure fluorescence intensity. The excitation wavelength is 488 nm and the emission wavelength is 525 nm. (4) Standardize the detection data based on cell count.
[0023] (V) Measurement of Oxidative Stress Levels: Intracellular LPO (BC5245, Solarbio) and GSH (BC1175, Solarbio) quantitative detection reagents were used to measure the levels of oxidative stress. Specific operational steps are as follows: (1) 1×10 6 One S2 cell was seeded into a 6-well culture plate and treated with the drug for 48 hours as described above. (2) Collect cells and homogenize them; (3) Centrifuge to collect the supernatant, and add the sample according to the instructions provided in the kit; (4) The quantitative values of LPO and GSH were determined in a 96-well plate, with LPO detection wavelengths of 532 nm and 600 nm and GSH detection wavelength of 412 nm. (5) All experiments were repeated at least 3 times, and the data were standardized based on cell counts.
[0024] (vi) Gene expression level detection (quantitative real-time reverse transcription polymerase chain reaction): RNA was extracted using qRT-PCR reagent, followed by reverse transcription and PCR reactions to detect the expression levels of Nox, Duox, SOD1, Gclc, and Gapdh genes; the specific operation steps are as follows: (1) RNA extraction: Total RNA was extracted from cells using TRIzol reagent (15596026, Invitrogen, Waltham, MA, USA) in accordance with the operating requirements; (2) Reverse transcription: RNA was reverse transcribed into cDNA using the PrimeScript™ II First Strand cDNA Synthesis Kit (RR601A, Takara), following the kit's reaction conditions; (3) qPCR reaction: TB Green Premix Ex TaqII (RR820, Takara) was used as a fluorescent reporter dye. PCR reaction was performed on the LightCycler® system (Roche). The reaction conditions were: 95℃ pre-denaturation for 30s; 95℃ denaturation for 5s; 60℃ annealing for 30s, for a total of 40 cycles. (4) Primer sequences are shown in Table 1 below:
[0025] ; (5) Using Gapdh as an internal reference gene, the relative expression level of the target gene was calculated using the 2⁻ΔΔCt method (Livak method).
[0026] (VII) Statistical Analysis: Student's t-test and two-way ANOVA were used to statistically analyze the test data and comprehensively evaluate the oxidative stress toxicity mediated by perifosine. All experimental data are expressed as mean ± standard error of mean (SEM). Statistical analysis was performed using GraphPad Prism software version 9.5 (GraphPad Inc., La Jolla, CA, USA): Student's t-test was used for comparisons between two groups; two-way ANOVA was used for comparisons between multiple groups, combined with Dunnett's multiple comparison test; the significance level was set as follows: *P<0.05; **P<0.01; ***P<0.0001.
[0027] Combination Figures 2-4 It was found that, compared with untreated cells, cell proliferation was inhibited for a period of time after treatment with perifoxanthin, and this inhibitory effect increased with increasing drug concentration. Simultaneously, apoptosis signals increased and the proportion of TUNEL-positive cells rose after drug treatment, indicating that perifoxanthin exhibits cytotoxicity in S2 cells. Furthermore, perifoxanthin treatment increased ROS levels, LPO accumulation, and decreased GSH levels in cells, and upregulated the expression levels of pro-oxidative genes Nox and Duox, while downregulating the expression levels of antioxidant genes SOD1 and Gclc, demonstrating that perifoxanthin-mediated cytotoxicity is closely related to the imbalance of the oxidative and antioxidant system homeostasis.
[0028] The above are preferred embodiments of the present invention. It should be noted that, for those skilled in the art, several improvements and modifications can be made without departing from the principle of the present invention, and these improvements and modifications should also be considered within the scope of protection of the present invention.
Claims
1. The application of a multi-index detection kit in evaluating the cytotoxic effects of perifosine-mediated cellular oxidative stress, characterized in that, The multi-index kit includes a cell proliferation detection reagent, a cell apoptosis detection reagent, a fluorescent probe for reactive oxygen species detection and corresponding buffer, a lipid peroxide quantitative detection reagent, a glutathione quantitative detection reagent, and a qRT-PCR reagent for detecting the expression levels of oxidation-antioxidant related genes. The qRT-PCR reagent includes an RNA extraction reagent, a reverse transcription reagent, a dye, and primers for the Nox, Duox, SOD1, Gclc, and Gapdh genes, with Gapdh serving as an internal reference gene. The cell proliferation detection reagent is CCK-8; the cell apoptosis detection reagent is TUNEL staining reagent; and the fluorescent probe for reactive oxygen species detection is the DCFH-DA fluorescent probe. The multi-index detection kit is used in the S2 cell line to detect perifosine-mediated oxidative stress toxicity in cells; The application includes the following steps: Step 1, Cell Culture and Drug Treatment: The S2 cell line was cultured under suitable conditions, treated with different concentrations of Perifosine for a specific time, and then the cells were collected. Step 2, Cell proliferation assay: Use the CCK-8 reagent in the kit to detect cell proliferation according to the operating instructions; Step 3, Apoptosis assay: Using the TUNEL staining reagent in the kit, the apoptosis status was identified according to the operating procedure; Step 4, determination of reactive oxygen species (ROS) content: The amount of ROS generated in cells was detected by fluorescence intensity using the DCFH-DA fluorescent probe and corresponding buffer. Step 5, Oxidative stress level determination: The intracellular LPO and GSH levels were measured using quantitative detection reagents for LPO and GSH, respectively. Step 6, gene expression level detection: RNA was extracted using qRT-PCR reagent, and reverse transcription and PCR reactions were performed to detect the expression levels of Nox, Duox, SOD1, Gclc, and Gapdh genes. Step 7, Statistical Analysis of Data: Student's t-test and two-way ANOVA were used to perform statistical analysis on the test data to comprehensively evaluate the oxidative stress toxicity mediated by Perifosine.
2. The application of the multi-index detection kit according to claim 1 in evaluating the toxic effects of perifosine-mediated cellular oxidative stress, characterized in that, The oxidative stress toxicity is specifically manifested in inhibiting cell proliferation, promoting cell apoptosis, increasing intracellular ROS and LPO levels, decreasing intracellular GSH levels, and causing upregulation of pro-oxidative gene expression and downregulation of antioxidant gene expression; the pro-oxidative genes are Nox and Duox, and the antioxidant genes are SOD1 and Gclc.
Citation Information
Patent Citations
Method for evaluating ecological health risk of typical neonicotinoid pesticide
CN121347794A
